Knuiman M W, Laird N M, Louis T A
Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115.
Mutat Res. 1987 Oct;180(2):171-82. doi: 10.1016/0027-5107(87)90212-0.
The Ames test is widely used in the screening of chemicals and compounds for potential carcinogenic effect. There is, however, considerable inter-laboratory variability in results from this assay. Using data from the RTI Collaborative Study of the EPA Ames Test Protocol, we show that their reported standard errors of estimates of mutagenicity fall far short of capturing day-to-day or laboratory-to-laboratory variation. We estimate the factors by which the standard errors must be inflated to account for these sources of variation. The laboratory protocol and previous studies suggest that much of this variation may be caused by factors that are relatively constant within days (e.g. technician, incubation temperature, S9 liver homogenate preparation) but vary over days and across laboratories. Therefore, such variation might be reduced through use of a reference compound tested on the same day and under the same conditions as the test chemical. This conjecture was, however, not supported by analyses that considered the positive control compound and a pure chemical as possible reference assays.
艾姆斯试验广泛用于筛选具有潜在致癌作用的化学物质和化合物。然而,该试验的结果在不同实验室之间存在相当大的差异。利用美国环境保护局(EPA)艾姆斯试验方案RTI合作研究的数据,我们发现他们报告的致突变性估计值的标准误差远远不足以捕捉每日或实验室之间的差异。我们估计了为考虑这些差异来源而必须增大标准误差的因子。实验室方案和先前的研究表明,这种差异的很大一部分可能是由在数天内相对恒定(例如技术人员、孵育温度、S9肝匀浆制备)但在数天之间以及不同实验室之间有所变化的因素引起的。因此,通过使用与受试化学物质在同一天、相同条件下进行测试的参考化合物,这种差异可能会减小。然而,考虑将阳性对照化合物和一种纯化学物质作为可能的参考试验的分析并未支持这一推测。